Insider Transactions in Q3 2022 at Generation Bio Co. (GBIO)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2022
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,828
-100.0%
|
$14,140
$5.24 P/Share
|
|
Sep 19
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
15,750
+7.59%
|
$78,750
$5.26 P/Share
|
|
Sep 16
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
33,481
+15.98%
|
$167,405
$5.48 P/Share
|
|
Sep 15
2022
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,610
-61.98%
|
$23,050
$5.32 P/Share
|
|
Sep 15
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
17,147
+10.74%
|
$85,735
$5.41 P/Share
|
|
Sep 14
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
5,600
+4.27%
|
$28,000
$5.29 P/Share
|
|
Sep 13
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
18,784
+13.55%
|
$93,920
$5.2 P/Share
|
|
Jul 15
2022
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,150
-1.16%
|
$99,050
$7.18 P/Share
|
|
Jul 15
2022
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
46,876
+3.69%
|
-
|
|
Jul 15
2022
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,367
-1.27%
|
$30,569
$7.18 P/Share
|
|
Jul 15
2022
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,876
+4.15%
|
-
|
|
Jul 15
2022
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,367
-29.36%
|
$30,569
$7.18 P/Share
|
|
Jul 15
2022
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,876
+50.0%
|
-
|
|
Jul 15
2022
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,422
-24.56%
|
$16,954
$7.18 P/Share
|
|
Jul 15
2022
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,250
+45.55%
|
-
|
|
Jul 15
2022
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,367
-2.05%
|
$30,569
$7.18 P/Share
|
|
Jul 15
2022
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,876
+6.53%
|
-
|
|
Jul 15
2022
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,367
-29.36%
|
$30,569
$7.18 P/Share
|
|
Jul 15
2022
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,876
+50.0%
|
-
|